Provided by Tiger Trade Technology Pte. Ltd.

InMed Pharmaceuticals Inc

0.9403
-0.0413-4.21%
Post-market: 0.94030.00000.00%19:08 EST
Volume:41.06K
Turnover:38.85K
Market Cap:2.64M
PE:-0.13
High:0.9816
Open:0.9800
Low:0.9000
Close:0.9816
52wk High:7.98
52wk Low:0.9000
Shares:2.80M
Float Shares:2.80M
Volume Ratio:0.79
T/O Rate:1.47%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-7.2148
EPS(LYR):-8.3630
ROE:-82.17%
ROA:-41.59%
PB:0.23
PE(LYR):-0.11

Loading ...

InMed Pharmaceuticals Inc. Held Annual Shareholder Meeting

Reuters
·
Dec 18, 2025

ADVISORY-Dated alerts on InMed Pharmaceuticals withdrawn

Reuters
·
Dec 15, 2025

InMed Pharmaceuticals Inc - Expects Negative Impact on Baymedica From New Act H.r. 5371 - SEC Filing

THOMSON REUTERS
·
Dec 15, 2025

BayMedica Faces Uncertainty as New Law Threatens Commercial Operations

Reuters
·
Dec 15, 2025

Why Did Vivakor Shares Surge 17% After Hours?

Benzinga_recent_news
·
Nov 20, 2025

What's Driving InMed's (INM) 22% After-Hours Surge?

Benzinga
·
Nov 20, 2025

InMed Pharmaceuticals Completes Key Study for INM-901

TIPRANKS
·
Nov 20, 2025

InMed Completes Key Pharmacokinetic Studies for Alzheimer’s Candidate INM-901

TIPRANKS
·
Nov 18, 2025

InMed Pharmaceuticals Completes Large Animal Study for Alzheimer's Drug Candidate INM-901

Reuters
·
Nov 18, 2025

InMed Pharmaceuticals reports $1.1 million in BayMedica revenues for Q1 fiscal 2026

Reuters
·
Nov 07, 2025

InMed Pharmaceuticals Inc. Announces Date for Upcoming Shareholder Meeting

Reuters
·
Oct 25, 2025

InMed Pharmaceuticals Files Amendment to Annual Report

Reuters
·
Oct 25, 2025

InMed Pharmaceuticals Inc. Files Initial Statement of Beneficial Ownership for Director John Steven Bathery

Reuters
·
Oct 24, 2025

InMed Pharmaceuticals Inc. Files Initial Statement of Beneficial Ownership for Director Neil Klompas

Reuters
·
Oct 18, 2025

InMed Pharmaceuticals Appoints John Bathery to Board of Directors; Bryan Baldasare to Step Down

Reuters
·
Oct 16, 2025

InMed Pharmaceuticals Appoints Neil Klompas to Board of Directors

Reuters
·
Oct 14, 2025

InMed Pharmaceuticals Reports Fiscal 2025 Results: Sales Increase 8% to $4.9M, Net Loss Widens to $8.2M

Reuters
·
Sep 23, 2025

InMed Pharmaceuticals FY Net Income USD -8.2 Million

THOMSON REUTERS
·
Sep 23, 2025

InMed Pharmaceuticals Inc. to Participate in H.C. Wainwright Annual Global Investment Conference

Reuters
·
Sep 08, 2025

InMed Pharmaceuticals Inc. Releases Corporate Presentation from H.C. Wainwright 27th Annual Global Investment Conference

Reuters
·
Sep 06, 2025